Notch and Wnt signaling in the emergence of hematopoietic stem cells

Blood Cells, Molecules, and Diseases

Volumn 51, Issue 4, 2013, Pages 264-270

  Bigas, Anna ^a   Guiu, Jordi ^a   Gama Norton, Leonor ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

AGM; Embryonic hematopoiesis; Hematopoiesis; HSC; Notch; Wnt

Indexed keywords

ANKYRIN; BETA CATENIN; DELTA LIKE LIGAND; EPIDERMAL GROWTH FACTOR; JAGGED1; NOTCH RECEPTOR; NUCLEAR FACTOR; NUCLEAR FACTOR RBPJ; PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BLOOD VESSEL; BONE MARROW; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL FATE; CELL LINE; CELL MATURATION; CELLULAR DISTRIBUTION; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; INTRACELLULAR SIGNALING; MICROENVIRONMENT; MISSENSE MUTATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; REGULATORY MECHANISM; WNT SIGNALING PATHWAY;

MAMMALIA;

AGM; AORTA-GONAD-MESONEPHROS; DELTA-LIKE LIGAND; DLL; EGF; EMBRYONIC HEMATOPOIESIS; EPIDERMAL GROWTH FACTOR; FETAL LIVER; FL; FRIZZLED; FZD; GAIN OF FUNCTION; GOF; HAIRY/ENHANCER-OF-SPLIT; HAIRY/ENHANCER-OF-SPLIT RELATED TRANSCRIPTIONAL FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HES; HRT; HSC; JAG; JAGGED LIGAND; LDL-RECEPTOR RELATED PROTEINS; LEF/TCF; LOF; LOSS OF FUNCTION; LRP; LYMPHOID ENHANCER FACTOR T-CELL FACTOR; NICD; NOTCH; NOTCH INTRACELLULAR DOMAIN; PB; PERIPHERAL BLOOD; RBPJ; RECOMBINATION SIGNAL BINDING PROTEIN FOR IMMUNOGLOBULIN KAPPA J REGION; WNT; YOLK SAC; YS;

ANIMALS; AORTA; EMBRYONIC DEVELOPMENT; GONADS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MESONEPHROS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84886308051     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2013.07.005     Document Type: Article

References (141)

1. Dzierzak E., Speck N.A. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nat. Immunol. 2008, 9(2):129-136.
2. Palis J., et al. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 1999, 126(22):5073-5084.
3. Tober J., et al. The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood 2007, 109(4):1433-1441.
4. Yoder M.C., Hiatt K. Engraftment of embryonic hematopoietic cells in conditioned newborn recipients. Blood 1997, 89(6):2176-2183.
5. Yoder M.C., et al. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity 1997, 7(3):335-344.
6. Samokhvalov I.M., Samokhvalova N.I., Nishikawa S. Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature 2007, 446(7139):1056-1061.
7. Chen M.J., et al. Erythroid/myeloid progenitors and hematopoietic stem cells originate from distinct populations of endothelial cells. Cell Stem Cell 2011, 9(6):541-552.
8. Pardanaud L., et al. Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 1996, 122(5):1363-1371.
9. Cumano A., et al. Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution. Immunity 2001, 15(3):477-485.
10. Zovein A.C., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell Stem Cell 2008, 3(6):625-636.
11. Chen M.J., et al. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009, 457(7231):887-891.
12. Muller A.M., et al. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1994, 1(4):291-301.
13. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996, 86(6):897-906.
14. de Bruijn M.F., et al. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J. 2000, 19(11):2465-2474.
15. Gekas C., et al. The placenta is a niche for hematopoietic stem cells. Dev. Cell 2005, 8(3):365-375.
16. Ivanovs A., et al. Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region. J. Exp. Med. 2011, 208(12):2417-2427.
17. Robin C., et al. Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 2009, 5(4):385-395.
18. Taoudi S., Medvinsky A. Functional identification of the hematopoietic stem cell niche in the ventral domain of the embryonic dorsal aorta. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(22):9399-9403.
19. Yokomizo T., et al. Three-dimensional imaging of whole midgestation murine embryos shows an intravascular localization for all hematopoietic clusters. Blood 2011, 117(23):6132-6134.
20. Johnson G.R., Moore M.A. Role of stem cell migration in initiation of mouse foetal liver haemopoiesis. Nature 1975, 258(5537):726-728.
21. Houssaint E. Differentiation of the mouse hepatic primordium. II. Extrinsic origin of the haemopoietic cell line. Cell Differ. 1981, 10(5):243-252.
22. Ema H., Nakauchi H. Expansion of hematopoietic stem cells in the developing liver of a mouse embryo. Blood 2000, 95(7):2284-2288.
23. Benz C., et al. Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs. Cell Stem Cell 2012, 10(3):273-283.
24. Ciriza J., et al. The migration of hematopoietic progenitors from the fetal liver to the fetal bone marrow: Lessons learned and possible clinical applications. Exp. Hematol. 2013, 41(5):411-423.
25. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137(2):216-233.
26. Bigas A., Espinosa L. Hematopoietic stem cells: to be or Notch to be. Blood 2012, 119(14):3226-3235.
27. Rebay I., et al. Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell 1991, 67(4):687-699.
28. de Celis J.F., Bray S.J. The Abruptex domain of Notch regulates negative interactions between Notch, its ligands and Fringe. Development 2000, 127(6):1291-1302.
29. Yamamoto S., et al. A mutation in EGF repeat-8 of Notch discriminates between Serrate/Jagged and Delta family ligands. Science 2012, 338(6111):1229-1232.
30. Okajima T., Irvine K.D. Regulation of notch signaling by o-linked fucose. Cell 2002, 111(6):893-904.
31. Fernandez-Valdivia R., et al. Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi. Development 2011, 138(10):1925-1934.
32. Moloney D.J., et al. Fringe is a glycosyltransferase that modifies Notch. Nature 2000, 406(6794):369-375.
33. Bruckner K., et al. Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 2000, 406(6794):411-415.
34. Logeat F., et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(14):8108-8112.
35. Tax F.E., Yeargers J.J., Thomas J.H. Sequence of C. elegans lag-2 reveals a cell-signalling domain shared with Delta and Serrate of Drosophila. Nature 1994, 368(6467):150-154.
36. Lindsell C.E., et al. Jagged: a mammalian ligand that activates Notch1. Cell 1995, 80(6):909-917.
37. Komatsu H., et al. OSM-11 facilitates LIN-12 Notch signaling during Caenorhabditis elegans vulval development. PLoS Biol. 2008, 6(8):e196.
38. Edbauer D., et al. Reconstitution of gamma-secretase activity. Nat.Cell Biol. 2003, 5(5):486-488.
39. Okochi M., et al. Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1. EMBO J. 2002, 21(20):5408-5416.
40. Schroeter E.H., Kisslinger J.A., Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 1998, 393(6683):382-386.
41. Struhl G., Adachi A. Nuclear access and action of notch in vivo. Cell 1998, 93(4):649-660.
42. Mumm J.S., et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell 2000, 5(2):197-206.
43. Deblandre G.A., Lai E.C., Kintner C. Xenopus neuralized is a ubiquitin ligase that interacts with XDelta1 and regulates Notch signaling. Dev. Cell 2001, 1(6):795-806.
44. Pavlopoulos E., et al. neuralized Encodes a peripheral membrane protein involved in delta signaling and endocytosis. Dev. Cell 2001, 1(6):807-816.
45. Itoh M., et al. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev. Cell 2003, 4(1):67-82.
46. Chen H., et al. Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. Nature 1998, 394(6695):793-797.
47. Meloty-Kapella L., et al. Notch ligand endocytosis generates mechanical pulling force dependent on dynamin, epsins, and actin. Dev. Cell 2012, 22(6):1299-1312.
48. Kao H.Y., et al. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. 1998, 12(15):2269-2277.
49. Wu L., et al. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat. Genet. 2000, 26(4):484-489.
50. Fryer C.J., et al. Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev. 2002, 16(11):1397-1411.
51. Yatim A., et al. NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol. Cell 2012, 48(3):445-458.
52. Robert-Moreno A., et al. RBPjkappa-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development 2005, 132(5):1117-1126.
53. Robert-Moreno A., et al. Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1. EMBO J. 2008, 27(13):1886-1895.
54. Fischer A., et al. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004, 18(8):901-911.
55. Guiu J., et al. Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling. J. Exp. Med. 2013, 210(1):71-84.
56. Minegishi N., et al. The mouse GATA-2 gene is expressed in the para-aortic splanchnopleura and aorta-gonads and mesonephros region. Blood 1999, 93(12):4196-4207.
57. Khandekar M., et al. A Gata2 intronic enhancer confers its pan-endothelia-specific regulation. Development 2007, 134(9):1703-1712.
58. Krebs L.T., et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14(11):1343-1352.
59. Krebs L.T., et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 2004, 18(20):2469-2473.
60. Shutter J.R., et al. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 2000, 14(11):1313-1318.
61. Duarte A., et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004, 18(20):2474-2478.
62. Kumano K., et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity 2003, 18(5):699-711.
63. Burns C.E., et al. Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev. 2005, 19(19):2331-2342.
64. North T.E., et al. Hematopoietic stem cell development is dependent on blood flow. Cell 2009, 137(4):736-748.
65. Urness L.D., Sorensen L.K., Li D.Y. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat. Genet. 2000, 26(3):328-331.
66. Sorensen L.K., et al. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev. Biol. 2003, 261(1):235-250.
67. You L.R., et al. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 2005, 435(7038):98-104.
68. Sorensen I., Adams R.H., Gossler A. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 2009, 113(22):5680-5688.
69. Xue Y., et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8(5):723-730.
70. High F.A., et al. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(6):1955-1959.
71. Oka C., et al. Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development 1995, 121(10):3291-3301.
72. Shi S., Stanley P. Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(9):5234-5239.
73. Donoviel D.B., et al. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 1999, 13(21):2801-2810.
74. Krebs L.T., et al. Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis 2003, 37(3):139-143.
75. Jiang R., et al. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. Genes Dev. 1998, 12(7):1046-1057.
76. Leung A., et al. Uncoupling VEGFA functions in arteriogenesis and hematopoietic stem cell specification. Dev. Cell 2013, 24(2):144-158.
77. Nakagawa M., et al. AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis. Blood 2006, 108(10):3329-3334.
78. Clements W.K., et al. A somitic Wnt16/Notch pathway specifies haematopoietic stem cells. Nature 2011, 474(7350):220-224.
79. Estrach S., et al. Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development 2006, 133(22):4427-4438.
80. Rodilla V., et al. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(15):6315-6320.
81. Corada M., et al. The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev. Cell 2010, 18(6):938-949.
82. Angers S., Moon R.T. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 2009, 10(7):468-477.
83. Willert K., et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003, 423(6938):448-452.
84. Hsieh J.C., et al. Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(7):3546-3551.
85. Tamai K., et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000, 407(6803):530-535.
86. Rubinfeld B., et al. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996, 272(5264):1023-1026.
87. Huber A.H., Nelson W.J., Weis W.I. Three-dimensional structure of the armadillo repeat region of beta-catenin. Cell 1997, 90(5):871-882.
88. Hulsken J., Behrens J., Birchmeier W. Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection. Curr. Opin. Cell Biol. 1994, 6(5):711-716.
89. Behrens J., et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998, 280(5363):596-599.
90. Graham T.A., et al. Crystal structure of a beta-catenin/Tcf complex. Cell 2000, 103(6):885-896.
91. Peifer M., et al. The vertebrate adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties. J. Cell Biol. 1992, 118(3):681-691.
92. Hulsken J., Birchmeier W., Behrens J. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J. Cell Biol. 1994, 127(6 Pt 2):2061-2069.
93. Aberle H., et al. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997, 16(13):3797-3804.
94. Gao Z.H., et al. Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(3):1182-1187.
95. Amit S., et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 2002, 16(9):1066-1076.
96. Liu C., et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108(6):837-847.
97. Bhanot P., et al. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 1996, 382(6588):225-230.
98. Salic A., et al. Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol. Cell 2000, 5(3):523-532.
99. Behrens J., et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996, 382(6592):638-642.
100. Molenaar M., et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996, 86(3):391-399.
101. van de Wetering M., et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 1997, 88(6):789-799.
102. Jho E.H., et al. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 2002, 22(4):1172-1183.
103. Pandur P., et al. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002, 418(6898):636-641.
104. Westfall T.A., et al. Wnt-5/pipetail functions in vertebrate axis formation as a negative regulator of Wnt/beta-catenin activity. J. Cell Biol. 2003, 162(5):889-898.
105. De A. Wnt/Ca2+ signaling pathway: a brief overview. Acta Biochim. Biophys. Sin. 2011, 43(10):745-756.
106. De Calisto J., et al. Essential role of non-canonical Wnt signalling in neural crest migration. Development 2005, 132(11):2587-2597.
107. Gao C., Chen Y.G. Dishevelled: The hub of Wnt signaling. Cell. Signal. 2010, 22(5):717-727.
108. Strutt D. Frizzled signalling and cell polarisation in Drosophila and vertebrates. Development 2003, 130(19):4501-4513.
109. Veeman M.T., Axelrod J.D., Moon R.T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev. Cell 2003, 5(3):367-377.
110. Ruiz-Herguido C., et al. Hematopoietic stem cell development requires transient Wnt/beta-catenin activity. J. Exp. Med. 2012, 209(8):1457-1468.
111. Corrigan P.M., et al. Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. Stem Cells Dev. 2009, 18(5):759-772.
112. Goodwin A.M., Sullivan K.M., D'Amore P.A. Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling. Dev. Dyn. 2006, 235(11):3110-3120.
113. Hwang Y.S., et al. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(40):16978-16983.
114. Cattelino A., et al. The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J. Cell Biol. 2003, 162(6):1111-1122.
115. Monkley S.J., et al. Targeted disruption of the Wnt2 gene results in placentation defects. Development 1996, 122(11):3343-3353.
116. Ishikawa T., et al. Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development 2001, 128(1):25-33.
117. Yamamizu K., et al. Convergence of Notch and beta-catenin signaling induces arterial fate in vascular progenitors. J. Cell Biol. 2010, 189(2):325-338.
118. Morali O.G., et al. IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 2001, 20(36):4942-4950.
119. Boisset J.C., et al. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 2010, 464(7285):116-120.
120. Bertrand J.Y., et al. Haematopoietic stem cells derive directly from aortic endothelium during development. Nature 2010, 464(7285):108-111.
121. Goessling W., et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 2009, 136(6):1136-1147.
122. Luis T.C., et al. Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. Blood 2009, 113(3):546-554.
123. Zhao C., et al. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007, 12(6):528-541.
124. Jeannet G., et al. Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin. Blood 2008, 111(1):142-149.
125. Cobas M., et al. Beta-catenin is dispensable for hematopoiesis and lymphopoiesis. J. Exp. Med. 2004, 199(2):221-229.
126. Koch U., et al. Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis. Blood 2008, 111(1):160-164.
127. Reya T., et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003, 423(6938):409-414.
128. Baba Y., Garrett K.P., Kincade P.W. Constitutively active beta-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors. Immunity 2005, 23(6):599-609.
129. Kirstetter P., et al. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat. Immunol. 2006, 7(10):1048-1056.
130. Scheller M., et al. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat. Immunol. 2006, 7(10):1037-1047.
131. Luis T.C., et al. Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell 2011, 9(4):345-356.
132. Huang J., et al. Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways. Nat. Med. 2012, 18(12):1778-1785.
133. Devgan V., et al. p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev. 2005, 19(12):1485-1495.
134. Dunwoodie S.L., et al. Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene Dll3 are associated with disruption of the segmentation clock within the presomitic mesoderm. Development 2002, 129(7):1795-1806.
135. Imayoshi I., et al. Hes genes and neurogenin regulate non-neural versus neural fate specification in the dorsal telencephalic midline. Development 2008, 135(15):2531-2541.
136. Ling K.W., et al. GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J. Exp. Med. 2004, 200(7):871-882.
137. Tsai F.Y., et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994, 371(6494):221-226.
138. Wang Y., Chang H., Nathans J. When whorls collide: the development of hair patterns in frizzled 6 mutant mice. Development 2010, 137(23):4091-4099.
139. Angus-Hill M.L., et al. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 2011, (12):4914-4919.
140. Huelsken J., et al. Requirement for beta-catenin in anterior-posterior axis formation in mice. J. Cell Biol. 2000, 148(3):567-578.
141. Haegel H., et al. Lack of beta-catenin affects mouse development at gastrulation. Development 1995, 121(11):3529-3537.